Orfadin (Nitisinone) is a life-saving medication for individuals with Hereditary Tyrosinemia Type 1 (HT-1), a rare genetic disorder. It prevents the buildup of toxic tyrosine byproducts in the body, protecting the liver and kidneys from severe damage. By reducing the need for liver transplants and improving survival rates, Orfadin has transformed HT-1 from a fatal condition to a manageable disorder. When combined with a low-tyrosine diet, Orfadin significantly enhances the quality of life for pa... moreOrfadin (Nitisinone) is a life-saving medication for individuals with Hereditary Tyrosinemia Type 1 (HT-1), a rare genetic disorder. It prevents the buildup of toxic tyrosine byproducts in the body, protecting the liver and kidneys from severe damage. By reducing the need for liver transplants and improving survival rates, Orfadin has transformed HT-1 from a fatal condition to a manageable disorder. When combined with a low-tyrosine diet, Orfadin significantly enhances the quality of life for patients affected by HT-1, offering hope for a healthier future.
Orfadin (Nitisinone) is a life-saving medication for individuals with Hereditary Tyrosinemia Type 1 (HT-1), a rare genetic disorder. It prevents the buildup of toxic tyrosine byproducts in the body, protecting the liver and kidneys from severe damage. By reducing the need for liver transplants and improving survival rates, Orfadin has transformed HT-1 from a fatal condition to a manageable disorder. When combined with a low-tyrosine diet, Orfadin significantly enhances the quality of life for pa... moreOrfadin (Nitisinone) is a life-saving medication for individuals with Hereditary Tyrosinemia Type 1 (HT-1), a rare genetic disorder. It prevents the buildup of toxic tyrosine byproducts in the body, protecting the liver and kidneys from severe damage. By reducing the need for liver transplants and improving survival rates, Orfadin has transformed HT-1 from a fatal condition to a manageable disorder. When combined with a low-tyrosine diet, Orfadin significantly enhances the quality of life for patients affected by HT-1, offering hope for a healthier future.